AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study,…
kchenJuly 16, 2021
Kineta Announces First Participant Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of KCP506
Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the first participant…
Shigeru Kinoshita, MD, PhD, has joined the medical advisory board at Aurion Biotech, whose mission is…
kchenJuly 15, 2021
In a report first published on the preprint server bioRxiv on June 22, Fred Hutchinson Cancer Research…
kchenJuly 14, 2021
Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…
kchenJuly 13, 2021
An innovative clinical trial led by Dr. Nicholas Vitanza, a neuro-oncologist at Seattle Children’s, shows…
kchenJuly 13, 2021
Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology…
kchenJuly 9, 2021
Three mutations in the Epsilon coronavirus spike protein dampen the neutralizing potency of antibodies induced…
kchenJuly 9, 2021
Seattle-based Icosavax has filed to go public via an IPO, just four years after it launched out…
kchenJuly 8, 2021
An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the…
kchenJuly 8, 2021
